{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:35:41Z","timestamp":1762508141931,"version":"3.44.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ucl.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T07:53:47Z","timestamp":1591602827000},"page":"399-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Radiation Therapy for Patients with Advanced Renal Cell Carcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Joseph A.","family":"Miccio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwadamilola T.","family":"Oladeru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung","family":"Jun Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly L.","family":"Johung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/1097-0142(197311)32:5<1056::AID-CNCR2820320505>3.0.CO;2-M","article-title":"Carcinoma of the kidney","volume":"32","author":"van der Werf-Messing","year":"1973","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00365597709179965","article-title":"Preoperative irradiation in the treatment of renal adenocarcinoma","volume":"11","author":"Juusela","year":"1977","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1464-410X.1973.tb12152.x","article-title":"The value of radiotherapy in the treatment of hypernephroma--a clinical trial","volume":"45","author":"Finney","year":"1973","journal-title":"Br J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/00365598709180784","article-title":"A\u00a0randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group","volume":"21","author":"Kjaer","year":"1987","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0360-3016(95)02029-2","article-title":"A\u00a0review of human cell radiosensitivity in\u00a0vitro","volume":"34","author":"Deschavanne","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib6","first-page":"978","article-title":"The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery","volume":"116","author":"Cochran","year":"2012","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ucl.2020.04.011_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000331190","article-title":"Brain metastasis from renal cell carcinoma","volume":"25","author":"Kim","year":"2012","journal-title":"Prog Neurol Surg"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-410X.2010.09895.x","article-title":"Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma","volume":"108","author":"Staehler","year":"2011","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/0284186X.2014.939298","article-title":"Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review","volume":"54","author":"Kothari","year":"2015","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3171\/2012.8.SPINE12303","article-title":"Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma","volume":"17","author":"Balagamwala","year":"2012","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/0284186X.2011.652741","article-title":"A\u00a0dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases","volume":"51","author":"Jhaveri","year":"2012","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib12","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","article-title":"Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma","volume":"82","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ucl.2020.04.011_bib13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/02841860600954875","article-title":"A\u00a0prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma","volume":"45","author":"Svedman","year":"2006","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib14","first-page":"e6","article-title":"The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT)","volume":"3","author":"Teh","year":"2007","journal-title":"Biomed Imaging Interv J"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.prro.2012.08.006","article-title":"Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease","volume":"3","author":"Corbin","year":"2013","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib16","first-page":"167","article-title":"When surgery is not an option in renal cell carcinoma: the evolving role of stereotactic body radiation therapy","volume":"33","author":"Miccio","year":"2019","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib17","first-page":"771","article-title":"Single fraction radiosurgery for the treatment of renal tumors","volume":"193","author":"Staehler","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib18","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ijrobp.2016.06.240","article-title":"Principal analysis of a phase ib trial of stereotactic body radiation therapy (SBRT) for primary kidney cancer","volume":"96","author":"Siva","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib19","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.ijrobp.2013.06.218","article-title":"A\u00a0phase 1 dose-escalation study of robotic radiosurgery in inoperable primary renal cell carcinoma","volume":"87","author":"McBride","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.radonc.2015.08.030","article-title":"Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma","volume":"117","author":"Ponsky","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib21","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1016\/j.ijrobp.2010.07.464","article-title":"Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors","volume":"78","author":"Kaplan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2014.07.043","article-title":"Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity","volume":"90","author":"Pham","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bju.13811","article-title":"Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial","volume":"120","author":"Siva","year":"2017","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.euf.2019.06.002","article-title":"The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis","volume":"5","author":"Correa","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib25","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1016\/j.clgc.2017.03.012","article-title":"Stereotactic body radiotherapy for large primary renal cell carcinoma","volume":"15","author":"Kaidar-Person","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"10.1016\/j.ucl.2020.04.011_bib26","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.clon.2016.04.002","article-title":"Stereotactic ablative body radiotherapy for primary renal cell carcinoma in non-surgical candidates: initial clinical experience","volume":"28","author":"Chang","year":"2016","journal-title":"Clin Oncol"},{"issue":"11","key":"10.1016\/j.ucl.2020.04.011_bib27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11547-014-0402-3","article-title":"Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma","volume":"119","author":"Wang","year":"2014","journal-title":"Radiol Med"},{"issue":"9","key":"10.1016\/j.ucl.2020.04.011_bib28","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/annonc\/mdq028","article-title":"Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials","volume":"21","author":"Tunio","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ucl.2020.04.011_bib29","first-page":"51","article-title":"Palliative radiation therapy for symptomatic control of inoperable renal cell carcinoma","volume":"4","author":"Nikolaev","year":"2015","journal-title":"Urol Case Rep"},{"issue":"2 Suppl","key":"10.1016\/j.ucl.2020.04.011_bib31","first-page":"S55","article-title":"Locally advanced renal cell carcinoma","volume":"1","author":"Otaibi","year":"2007","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","article-title":"Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease","volume":"30","author":"Janzen","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ucl.2020.04.011_bib33","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3332\/ecancer.2017.750","article-title":"Intraoperative radiotherapy: review of techniques and results","volume":"11","author":"Pilar","year":"2017","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00066-012-0272-3","article-title":"Intraoperative EBRT and resection for renal cell carcinoma: twenty-year outcomes","volume":"189","author":"Calvo","year":"2013","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2013.11.207","article-title":"Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma","volume":"88","author":"Paly","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.adro.2019.07.018","article-title":"Utilization of stereotactic ablative body radiation therapy for intact renal cell carcinoma: trends in treatment and predictors of outcome","volume":"5","author":"Wegner","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.euf.2017.12.007","article-title":"The development of brain metastases in patients with renal cell carcinoma: epidemiologic trends, survival, and clinical risk factors using a population-based cohort","volume":"5","author":"Sun","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib39","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1016\/j.clgc.2018.03.015","article-title":"Utilization of stereotactic radiosurgery for renal cell carcinoma brain metastases","volume":"16","author":"Haque","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib40","first-page":"372","article-title":"Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery","volume":"6","author":"Amendola","year":"2000","journal-title":"Cancer J"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00536-8","article-title":"The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma","volume":"47","author":"Goyal","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5 Suppl","key":"10.1016\/j.ucl.2020.04.011_bib42","first-page":"489","article-title":"Gamma knife radiosurgery for renal cell carcinoma brain\u00a0metastases","volume":"97","author":"Hernandez","year":"2002","journal-title":"J\u00a0Neurosurg"},{"issue":"11","key":"10.1016\/j.ucl.2020.04.011_bib43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1442-2042.2002.00531.x","article-title":"Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: Results in 42 patients","volume":"9","author":"Hoshi","year":"2002","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib44","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0360-3016(00)00804-X","article-title":"Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma","volume":"48","author":"Ikushima","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib45","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1227\/NEU.0b013e31822b2fdc","article-title":"Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases","volume":"69","author":"Kano","year":"2011","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1078-1439(03)00104-2","article-title":"LINAC radiosurgery for brain metastasis of renal cell carcinoma","volume":"22","author":"Noel","year":"2004","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib47","first-page":"760","article-title":"Gamma surgery for intracranial metastases from renal cell carcinoma","volume":"92","author":"Payne","year":"2000","journal-title":"J\u00a0Neurosurg"},{"issue":"9","key":"10.1016\/j.ucl.2020.04.011_bib48","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/cncr.23857","article-title":"Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery","volume":"113","author":"Samlowski","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-010-0170-4","article-title":"Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema","volume":"98","author":"Shuto","year":"2010","journal-title":"J\u00a0Neurooncol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2004-818511","article-title":"Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma","volume":"47","author":"Muacevic","year":"2004","journal-title":"Minim Invasive Neurosurg"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00066-010-2055-z","article-title":"Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients","volume":"186","author":"Fokas","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ucl.2020.04.011_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2018.04.008","article-title":"Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group","volume":"98","author":"Meyer","year":"2018","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib54","first-page":"558","article-title":"Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy","volume":"19","author":"McTyre","year":"2017","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib55","first-page":"2973","article-title":"Predicting the risk of developing new cerebral lesions after stereotactic radiosurgery or fractionated stereotactic radiotherapy for brain metastases from renal cell carcinoma","volume":"38","author":"Rades","year":"2018","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ucl.2020.04.011_bib57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fonc.2018.00551","article-title":"Repeated courses of radiosurgery for new brain metastases to defer whole brain radiotherapy: feasibility and outcome with validation of the new prognostic metric brain metastasis velocity","volume":"8","author":"Fritz","year":"2018","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib58","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2011.12.009","article-title":"Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control","volume":"84","author":"Choi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/neuros\/nyy146","article-title":"Preoperative vs postoperative radiosurgery for resected brain metastases: a review","volume":"84","author":"Prabhu","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ucl.2020.04.011_bib60","first-page":"1","article-title":"Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases","author":"Juloori","year":"2019","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","article-title":"Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases","volume":"125","author":"Kohutek","year":"2015","journal-title":"J\u00a0Neurooncol"},{"issue":"8","key":"10.1016\/j.ucl.2020.04.011_bib62","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","article-title":"Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation","volume":"4","author":"Martin","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ucl.2020.04.011_bib63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fonc.2018.00395","article-title":"Diagnosis and management of radiation necrosis in patients with brain metastases","volume":"8","author":"Vellayappan","year":"2018","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/14737175.2016.1135736","article-title":"Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overview","volume":"16","author":"Sharma","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib65","first-page":"373","article-title":"The management of brain necrosis as a result of SRS treatment for intra-cranial tumors","volume":"3","author":"Patel","year":"2014","journal-title":"Transl Cancer Res"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0090-4295(81)90455-6","article-title":"Osseous metastases secondary to renal cell carcinoma","volume":"18","author":"Swanson","year":"1981","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib67","first-page":"1163","article-title":"Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma","volume":"159","author":"Levy","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib68","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/annonc\/mdq605","article-title":"Pain management in spinal metastases: the role of percutaneous vertebral augmentation","volume":"22","author":"Kassamali","year":"2010","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib69","first-page":"548","article-title":"Treatment of spinal metastases from kidney cancer by presurgical embolization and resection","volume":"73","author":"Sundaresan","year":"1990","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib70","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3171\/2015.8.SPINE15844","article-title":"Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I\/II trials","volume":"24","author":"Ghia","year":"2016","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3171\/spi.2005.3.4.0288","article-title":"Stereotactic radiosurgery for spinal metastases from renal cell carcinoma","volume":"3","author":"Gerszten","year":"2005","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib72","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2009.03.062","article-title":"Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy","volume":"76","author":"Nguyen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2017.01.032","article-title":"Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases","volume":"98","author":"Wang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib74","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/2016.4.SPINE16229","article-title":"Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma","volume":"25","author":"Miller","year":"2016","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib75","first-page":"48","article-title":"The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases","volume":"3","author":"Kumar","year":"2015","journal-title":"Neurooncol Pract"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-014-1455-9","article-title":"Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study","volume":"119","author":"Sohn","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.ucl.2020.04.011_bib77","first-page":"6384253","article-title":"The efficacy of conventionally fractionated radiation in the management of osseous metastases from metastatic renal cell carcinoma","volume":"2018","author":"Ganju","year":"2018","journal-title":"J\u00a0Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib78","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/j.prro.2015.05.004","article-title":"Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?","volume":"5","author":"Amini","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2020.04.011_bib79","first-page":"746","article-title":"Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model","volume":"158","author":"DiBiase","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","article-title":"Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma","volume":"77","author":"Wersall","year":"2005","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib81","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/COC.0b013e31825d52b2","article-title":"Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma","volume":"36","author":"Ranck","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib82","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.euo.2019.05.007","article-title":"Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies","volume":"2","author":"Zaorsky","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"17","key":"10.1016\/j.ucl.2020.04.011_bib83","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-16-2946","article-title":"A\u00a0pilot study of stereotactic body radiation therapy combined with cytoreductive nephrectomy for metastatic renal cell carcinoma","volume":"23","author":"Singh","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ucl.2020.04.011_bib84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijrobp.2019.07.023","article-title":"Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer","volume":"105","author":"Zhang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib85","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.prro.2017.04.009","article-title":"Potential abscopal response to dual checkpoint blockade in RCC after reirradiation using dose-painting SBRT","volume":"7","author":"LaPlant","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2020.04.011_bib86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/17843286.2016.1201614","article-title":"Abscopal effect in metastatic renal cell carcinoma","volume":"72","author":"Van de Walle","year":"2017","journal-title":"Acta Clin Belg"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib87","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euo.2018.09.013","article-title":"Combining immunotherapy with radiotherapy for the treatment of genitourinary malignancies","volume":"2","author":"Solanki","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2020.04.011_bib88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s007010050139","article-title":"Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients","volume":"140","author":"Sch\u00f6ggl","year":"1998","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.ucl.2020.04.011_bib89","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ijrobp.2011.03.044","article-title":"Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival","volume":"82","author":"Kim","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ucl.2020.04.011_bib90","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.radonc.2018.04.028","article-title":"Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014","volume":"127","author":"Stenman","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2020.04.011_bib91","first-page":"70","article-title":"Role of stereotactic body radiation therapy for the management of oligometastatic renal cell carcinoma","volume":"201","author":"Franzese","year":"2019","journal-title":"J\u00a0Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014320300264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014320300264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:38:52Z","timestamp":1758807532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014320300264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0094014320300264"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2020.04.011","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Patients with Advanced Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}